Drugmaker AstraZeneca said on Friday its lung cancer drugs Imfinzi and Imjudo have been approved by the US Food and Drug Administration (FDA) when used along with chemotherapy for treatment of adults with stage IV non-small cell lung cancer.
US FDA approves AstraZeneca's lung cancer drugs
AstraZeneca's cancer medicine Imfinzi Reuters Photo
&uuid=(email))